Drug: Etopophos (Etoposide Phosphate) to Treat SCLC

Etopophos for SCLC

Small-Cell Lung Cancer cases are on the rise. Etopophos is a chemotherapy drug used for prevention of cancer cells. It is approved for the treatment of small cell lung cancer. It works to kill the cancer cells and the faster cells divide, the more likely the drug kills those cells. This chemotherapy drug is effective at killing cells that divide rapidly.

Dosage

The drug is given as a slow injection into the vein by healthcare provider. Etopophos for injection is an antineoplastic agent and is available for intravenous infusion. The recommended dosage of Etopophos is 35 mg/2 per day administrated intravenously over 5 minutes to 3.5 hours for 4 days or 50 mg/m2 administrated intravenously over 5 minutes to 3.5 hours for 5 days. The dosage should be administered under the supervision of qualified physician experienced in the use of cancer chemotherapeutic agents. In the form of tablet, it is taken by mouth.

Precautions to be Taken

You should inform your doctor about any other medications you take before starting the lung cancer treatment. Both men and women should not conceive a child while taking this drug. If you are pregnant, inform your health care professional prior to starting the Etoposide treatment. Also, women should not breast feed while taking it.

Possible Side Effects

The common side effects of Etopophos include:

  • Fever, body aches, sores in the mouth, pale skin
  • Irritation or skin burning
  • Short of breath
  • Rapid heart rate

If severe reactions occur, the drug should be reduced in dosage or discontinued. You should take appropriate corrective measures according to clinical judgment of the physician.

What are your views about the effectiveness of drugs in the treatment of lung cancer? Let us know your thoughts in the comments section below.

 

The information offered in this blog is for educational purposes only. It is not a substitute for medical advice.

Leave a Reply